Patterns of glaucomatous visual field progression identified by three progression criteria - 25/08/11
, Eytan Z. Blumenthal, MD a, b, John Pascual, BS a, Gavin McEwan, BS a, Robert N. Weinreb, MD a, Felipe Medeiros, MD a, Pamela A. Sample, PhD aRésumé |
Purpose |
To determine typical patterns of repeatable glaucomatous visual field progression.
Design |
Retrospective analysis of data obtained from two prospective studies.
Methods |
Included were 72 eyes of 72 patients tested up to six times over 2 years, and 40 eyes of 40 patients followed annually for up to 12 years. Each patient had two abnormal baseline visual fields, abnormal optic nerves, and serial fields. Progression was identified using three methods: by glaucoma change probability using total deviation (GCP-TD) and pattern deviation (GCP-PD) plots and by a clinical criteria. Progression was categorized as deepening or expansion of an existing scotoma, or a new scotoma.
Results |
The percentage of eyes repeatably progressed ranged from 17% to 27%. The most common pattern of progression was a deepening of an existing scotoma in the annual group, followed by expansion. With two follow-ups required, percentages for deepening only were 20% (clinical classifier). A combination of expansion and deepening was most common for the GCP criteria: 15% (GCP-TD classifier), and 10% (GCP-PD classifier) for the annual group. For the semiannual group, deepening was most common with the clinical criteria (11% of eyes), and deepening with expansion was most common by GCP criteria (14%, GCP-TD and GCP-PD). No eyes showed repeatable new scotomas.
Conclusions |
Glaucomatous visual fields progress in the area of the visual field where baseline testing showed an existing scotoma. Follow-up testing might be improved by concentrating on already defective locations and using sparser test patterns or screening algorithms in normal areas of the visual field.
Le texte complet de cet article est disponible en PDF.Plan
| This research was supported by a grant from the National Eye Institute, NEI EY 08208 (P.A.S.), Glaucoma Research Foundation (P.A.S.), Research to Prevent Blindness and Alcon (P.A.S.), Foundation for Eye Research (E.Z.B., F.M.). Research support from Carl-Zeiss Meditec, Inc. (P.A.S., R.N.W.). |
Vol 138 - N° 6
P. 1029-1036 - décembre 2004 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
